Idexx Laboratories | IDXX - Cost Of Sales

Stock Price
556.12
Daily Change
10.33 1.89%
Monthly
-4.62%
Yearly
6.60%
Q2 Forecast
518.16

Idexx Laboratories reported $418.08M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 303.5M 60.47M Mar/2026
AngioDynamics USD 37.29M 786K Sep/2025
Dentsply International USD 453M 65M Mar/2026
Dexcom USD 441.6M 25.3M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Fujifilm JPY 550.58B 40.74B Mar/2026
Globus Medical USD 263.59M 26.88M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Masimo USD 152.8M 12.4M Mar/2026
Neogen USD 112.2M 5.81M Dec/2025
Orthofix International USD 66.63M 6.4M Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
ResMed USD 551.67M 4.17M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Steris USD 891.3M 50.6M Mar/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Zoetis USD 672M 71M Mar/2026